awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44150769-2C0F811E-1A2F-4E79-BB36-CE8DF46AA79F
Q44150769-2C0F811E-1A2F-4E79-BB36-CE8DF46AA79F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44150769-2C0F811E-1A2F-4E79-BB36-CE8DF46AA79F
Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
P2860
Q44150769-2C0F811E-1A2F-4E79-BB36-CE8DF46AA79F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44150769-2C0F811E-1A2F-4E79-BB36-CE8DF46AA79F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a178c309d2e92b93c81037c179a1fb27751a7e43
P2860
The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer.